|By Marketwired .||
|April 30, 2014 11:37 AM EDT||
NEW YORK, NY -- (Marketwired) -- 04/30/14 -- According to a new study from the Johns Hopkins Kimmel Cancer Center, men with evidence of chronic prostate inflammation may be twice as likely to develop prostate cancer as those without. Moreover, the study participants with chronic prostate inflammation were more likely to be diagnosed with high-grade, aggressive prostate cancer.
While the observational study did not demonstrate a clear cause-and-effect relationship between prostate inflammation and cancer, the association was significant enough to warrant further investigation. David Samadi, MD, leading robotic prostate surgeon and Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, believes the connection could lead to better prostate cancer risk analysis.
"Expanding our understanding of prostate cancer risk factors, expands our opportunity for vigilance over the men most likely to be affected," said Dr. Samadi. "A deeper exploration of the inflammation link may also yield opportunities for prevention and risk mitigation."
Among the 400 study participants, 86.2 percent of overall prostate cancer cases and 88.4 percent of high-grade cases had at least one core biopsy indicating prostate tissue inflammation. Among the men without prostate cancer, prostate inflammation was detected in 78.2 percent of the cases.
The study findings were published in the Journal Cancer Epidemiology, Biomarkers & Prevention on April 18th, http://cebp.aacrjournals.org/content/early/2014/04/14/1055-9965.EPI-13-1126.abstract
Benign prostatic hyperplasia (BPH), commonly diagnosed in men over age 55, is an enlargement of the prostate gland caused by an overgrowth of cells. While BPH is not directly linked to prostate cancer, the close associations between elevated prostate-specific antigen levels (PSA), chronic prostate inflammation, and prostate cancer may now warrant closer attention.
"Prostate inflammation is highly common and men with chronic BPH need not be alarmed of cancer risk," assured Dr. Samadi. "These men have the assurance of regular screenings and attention to their prostate health. That's the biggest prostate cancer prevention strategy we have today."
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2580293
David B. Samadi, M.D
Chairman of Urology
Chief of Robotic Surgery at Lenox Hill Hospital
485 Madison Avenue
New York, NY 10022
SYS-CON Events announced today that Pulzze Systems will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Pulzze Systems, Inc. provides infrastructure products for the Internet of Things to enable any connected device and system to carry out matched operations without programming. For more information, visit http://www.pulzzesystems.com.
Sep. 25, 2016 06:45 AM EDT Reads: 1,726
SYS-CON Events announced today the Enterprise IoT Bootcamp, being held November 1-2, 2016, in conjunction with 19th Cloud Expo | @ThingsExpo at the Santa Clara Convention Center in Santa Clara, CA. Combined with real-world scenarios and use cases, the Enterprise IoT Bootcamp is not just based on presentations but with hands-on demos and detailed walkthroughs. We will introduce you to a variety of real world use cases prototyped using Arduino, Raspberry Pi, BeagleBone, Spark, and Intel Edison. Y...
Sep. 25, 2016 06:30 AM EDT Reads: 2,794
Sep. 25, 2016 05:45 AM EDT Reads: 1,601
Sep. 25, 2016 05:30 AM EDT Reads: 976
Sep. 25, 2016 04:45 AM EDT Reads: 1,498
Sep. 25, 2016 04:15 AM EDT Reads: 1,678
Sep. 25, 2016 04:15 AM EDT Reads: 1,380
Sep. 25, 2016 03:15 AM EDT Reads: 3,349
Sep. 25, 2016 03:00 AM EDT Reads: 1,470
Sep. 25, 2016 02:45 AM EDT Reads: 1,708
Sep. 25, 2016 02:45 AM EDT Reads: 874
Sep. 25, 2016 02:15 AM EDT Reads: 1,211
Sep. 25, 2016 12:45 AM EDT Reads: 1,036
Sep. 25, 2016 12:45 AM EDT Reads: 1,929
Sep. 25, 2016 12:30 AM EDT Reads: 1,598